Arvinas, Inc. (ARVN)
Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC
客服專線︰ +852 3018 4526
交易日︰全日24小時 | 非交易日：9:00-18:00
